Two Sigma Advisers’s CapForce IBD 50 ETF FFTY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
– Sell
-11,900
Closed -$330K – 2364
2024
Q2
$330K Sell
11,900
-21,800
-65% -$594K ﹤0.01% 2031
2024
Q1
$931K Sell
33,700
-15,700
-32% -$410K ﹤0.01% 1614
2023
Q4
$1.2M Buy
49,400
+30,100
+156% +$685K ﹤0.01% 1550
2023
Q3
$432K Sell
19,300
-10,200
-35% -$246K ﹤0.01% 1843
2023
Q2
$755K Buy
29,500
+18,600
+171% +$441K ﹤0.01% 1651
2023
Q1
$258K Buy
+10,900
New +$250K ﹤0.01% 2193

Other funds holding FFTY

Two Sigma Advisers's FFTY Position: Q3 2024 in Review

Two Sigma Advisers sold out of CapForce IBD 50 ETF (FFTY) in Q3 2024, closing a stake of 11,900 shares — an estimated $330K sold.

Two Sigma Advisers first reported a position in FFTY in Q1 2023 and held it in 6 quarters. The position peaked at $1.2M in Q4 2023. 29 funds tracked by Wall St. Rank hold FFTY as of Q3 2024.

  • Two Sigma Advisers reported no remaining CapForce IBD 50 ETF position as of Q3 2024 after selling out during the quarter.
  • Two Sigma Advisers sold 11,900 CapForce IBD 50 ETF shares in Q3 2024, an estimated $330K.
  • Two Sigma Advisers first reported a position in CapForce IBD 50 ETF in Q1 2023 and held it in 6 quarters.
  • Two Sigma Advisers's CapForce IBD 50 ETF position peaked at $1.2M in Q4 2023.
  • 29 funds tracked by Wall St. Rank held CapForce IBD 50 ETF as of Q3 2024.

Based on Two Sigma Advisers's 13F filing for Q3 2024, filed 14 Nov 2024.